Animal Parasiticides Market to Reach US$ 16.9 Billion by 2035, Expanding at 6.6% CAGR | Fact.MR Report

The global animal parasiticides market, valued at USD 7.9 billion in 2022, is projected to reach USD 13.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% over the forecast period. This market is pivotal in addressing parasitic infections in livestock and companion animals, driven by rising animal health awareness, increasing pet ownership, and growing demand for animal-derived food products. The surge in zoonotic diseases and foodborne illnesses further underscores the importance of parasiticides in ensuring animal welfare and food safety, making them essential in modern veterinary care.

The market is propelled by technological advancements, such as innovative formulations and delivery systems, and increased investments in veterinary healthcare. The growing prevalence of external parasites like ticks and fleas, coupled with the need to protect food-producing animals, fuels demand for effective parasiticides. Emerging trends include the development of genetically engineered treatments and eco-friendly solutions to address environmental concerns, positioning the market for robust growth.

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

Market Analysis

The animal parasiticides market is driven by the rising incidence of parasitic infections, particularly in regions with expanding livestock populations and suboptimal farm management practices. Increasing pet adoption, especially in North America and Europe, boosts demand for companion animal treatments, while growing consumption of animal-based proteins globally necessitates robust parasite control for food-producing animals.

Government initiatives, such as the European Union's USD 2.2 billion allocation for animal health programs from 2014 to 2020, support market growth by funding disease prevention measures. However, challenges such as high product costs, substantial R&D investments, and limited awareness in rural areas hinder market expansion. Environmental concerns regarding the disposal of parasiticide residues and the lack of adequate financing for research in developing regions also pose significant barriers to growth.

Segment Analysis

The ectoparasiticides segment dominates the market, holding a 52% share in 2022, driven by the prevalence of external parasites like ticks, lice, and fleas, which pose risks to both animals and humans. This segment is expected to grow at a CAGR of 6.3% through 2032, fueled by innovations in formulations like spot-on treatments and sprays. The companion animals segment is the fastest-growing, with a projected CAGR of 6.1%, driven by rising pet ownership and heightened awareness of zoonotic diseases. Within this segment, dogs and felines are the primary focus due to their high adoption rates. Food-producing animals, including cattle, poultry, and swine, also represent a significant market share, driven by the need to ensure food safety and productivity in livestock farming.

Country-wise Insights

In the United States, the animal parasiticides market is projected to reach USD 1.5 billion by 2032, growing at a CAGR of 6.5%. The market is driven by high pet ownership rates, with 67% of U.S. households owning pets according to the American Pet Products Association, and stringent regulations by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS). Increased R&D investments by key players like Zoetis and Merck Animal Health further bolster growth, focusing on advanced treatments for companion and livestock animals. In the United Kingdom, the market is supported by rising pet care awareness and government-backed animal welfare initiatives. The U.K.'s focus on reducing zoonotic disease transmission and improving livestock health drives demand for ectoparasiticides, though the market is smaller compared to the U.S. due to a more limited livestock sector.

Buy report: https://www.factmr.com/checkout/4316

Key Players
• Zoetis, Inc.
• Merck Animal Health
• Ceva Sante Animale
• Boehringer Ingelheim GmbH
• Elanco Animal Health
• Bayer AG
• Vetoquinol
• Virbac
• The Chanelle Group
• Bimeda Animal Health

Strategic Outlook and Industry Trends

The animal parasiticides market is evolving with a focus on innovation and sustainability. Companies are investing in advanced delivery systems, such as Merck's SPHEREON technology for freeze-dried poultry vaccines and Zoetis' Simparica Trio, a comprehensive canine parasiticide. Strategic acquisitions, like Zoetis' purchase of NewMetrica in 2022 to enhance quality-of-life assessments, reflect a commitment to holistic animal care. The industry is also witnessing a shift toward eco-friendly parasiticides to address environmental concerns, alongside increased direct-to-consumer sales to improve accessibility and margins. As global demand for animal-derived proteins grows and zoonotic disease risks persist, manufacturers are likely to prioritize R&D and partnerships to develop cost-effective, high-efficacy solutions, ensuring sustained market growth.

Browse Full Report on: https://www.factmr.com/report/4316/animal-parasiticides-market

Segmentation of Animal Parasiticides Market

By Product Type:
• Ectoparasiticides (Oral Tablets, Dips, Spray, Spot-on, Others)
• Endoparasiticides (Oral Suspension, Injectable, Feed Additives, Others)
• Endectocides

By Species:
• Food-Producing Animals (Cattle, Poultry, Swine, Others)
• Companion Animals (Dogs, Felines, Others)
• Other Livestock

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Animal Probiotic Market
https://www.factmr.com/report/1067/animal-probiotics-market

Animal Antibiotics Market
https://www.factmr.com/report/1049/animal-antibiotics-market

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.